Sativa Wellness Group EC clarification may facilitate the opening up of new markets in the future

Sativa Wellness Group plc (AQSE:SWEL) has confirmed that the European Commission (EC), the executive branch of the European Union (EU), has concluded that CBD (Cannabidiol) is not considered to be a drug within the meaning the UN Single Convention on Narcotic Drugs of 1961, following the recent landmark ruling from the EU’s highest court.  As a consequence, the EC confirmed that CBD qualifies as a food, and is therefore subject to EU law on the free movement of goods among member states. 

Subsequently, the European Food Safety Authority (EU FSA) has resumed reviewing novel food authorisation applications for CBD products, a decision which is welcomed by the Company, which operates CBD extraction and production in the UK and Europe. 

The Company intends to submit its novel food dossier that is being prepared for the UK Food Standards Agency (UK FSA) in parallel to the EU FSA, which will be a seamless process as the submission criteria for the two agencies are aligned.

United Nations

The United Nations has considered a number of recommendations from the World Health Organisation (WHO) to reclassify cannabis and its derivatives, and recently voted in favour to remove cannabis from Schedule IV of the 1961 UN Single Convention, the category of the world’s most dangerous drugs. 

The Company believes that this long-anticipated decision, whilst having no immediate effect on local government classification at a country level, opens the door to recognising the medicinal and therapeutic potential of cannabis, and paves the way for additional scientific research, such as the Companies research partnership with King’s College London into the efficacy of different cannabinoids in treating respiratory conditions. 

US House of Representatives

The US House of Representatives recently passed a federal bill to decriminalise cannabis at the national level.  Whilst cannabis has been decriminalised in several states in the US, including California, Colorado, Nevada and Washington, it remains illegal at the federal level. The House calls for removing cannabis from the list of federally controlled substances and clears the way to erase certain federal convictions. 

Whilst this bill is the first step to approval at the federal level – to become law, the bill needs to pass the Senate and be signed by the president – if passed into law, it would bridge the gap between state and federal legislation, and facilitate the emerging industry and access to medicinal cannabis across the US.   

“Sativa Wellness welcomes the clarity that these regulatory updates bring to the CBD wellness and medicinal cannabis industry in Europe, the US and globally.  We believe that a well-regulated cannabis sector will lead to consumers benefitting from safe, compliant and quality products, such as our Goodbody CBD brands, and opens the pathway for patients to benefit from further research into the efficacy of medicinal cannabis.  This news will allow us to continue with our European expansion plans, and may facilitate the opening up of new markets in the future”, said Henry Lees-Buckley, CEO of the Sativa Wellness Group Inc.

Click to view all articles for the EPIC:
Or click to view the full company profile:
Facebook
Twitter
LinkedIn
DirectorsTalk

More articles like this

Sativa Wellness Group Management Share Compensation Arrangements

Sativa Wellness Group plc (AQSE:SWEL / CNSX:SWEL) today announced certain management share compensation arrangements and amendments that have been approved by the Board of Directors with a view to both incentivising and aligning management and shareholder interests. Firstly, following

Use of Cannabidiol for the treatment of Anxiety

A macro-analysis of 49 different research papers (focusing primarily on animal studies) on the effects of CBD regarding multiple anxiety or stress-oriented disorders, such as Post-Traumatic Stress Disorder, Generalised Anxiety Disorder, and Social Anxiety Disorder to

The “Runner’s High” and Endocannabinoids

A runner’s high is a sense of well-being some people experience after prolonged exercise. For decades, it was hypothesized that exercise-induced endorphin release is solely responsible for a runner’s high, but recent evidence has suggested that

CBD bioavailability and why it matters

Wealth, friends, and even spouses, if lost, can be regained or acquired again somehow. But the body, once gone, will never come back- no matter how hard we try to revive the life that’s lost. Our

Finding relief from aches and pains

Everyone at some point of their life will experience some aches and pain, and it could be because of a whole range of different reasons. For some of us, that would be a bit of joint

CBD and mental health: A systematic analysis

There is a lot of research about the positive effects of CBD and Mental Health.  This report is a systematic analysis of a multitude of different research papers and conducted trials with regards to CBD’s impact

General benefits of CBD

CBD has been reported to help people in a number of ways. From pain relief, memory, and sleep to name a few, there’s a chance that we could all benefit from CBD in one way or

CBD and Diabetes: How can it help?

Close to 4.9 million people in the UK have been diagnosed with diabetes, with a further 850,000 people suspected to be living with undiagnosed type 2 diabetes. To add on to this, 13.6 million people in

The effects of cannabidiol on cerebral blood flow

The primary aim of this research paper was to investigate how CBD influences cerebral blood flow (CBF) in regions involved in memory processing. It was conducted under a randomised, crossover, double-blind design in which 15 healthy

Sativa Wellness Group Report record Q3 revenues (Interview)

Sativa Wellness Group Inc. (AQSE:SWEL / CNSX:SWEL) CEO Mark Howells joins DirectorsTalk Interviews to discuss a record quarterly profit in Q3 2021. Mark talks us through the numbers, explains how sustainable the performance is and plans